664 related articles for article (PubMed ID: 26502195)
1. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
[TBL] [Abstract][Full Text] [Related]
2. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
4. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH
Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R
Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403
[TBL] [Abstract][Full Text] [Related]
7. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
Dachs E; Hereu M; Piedrafita L; Casanovas A; Calderó J; Esquerda JE
J Neuropathol Exp Neurol; 2011 Jun; 70(6):444-61. PubMed ID: 21572339
[TBL] [Abstract][Full Text] [Related]
8. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
Turner BJ; Alfazema N; Sheean RK; Sleigh JN; Davies KE; Horne MK; Talbot K
Neurobiol Aging; 2014 Apr; 35(4):906-15. PubMed ID: 24210254
[TBL] [Abstract][Full Text] [Related]
11. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.
Tejero R; Lopez-Manzaneda M; Arumugam S; Tabares L
Hum Mol Genet; 2016 Nov; 25(21):4703-4716. PubMed ID: 28173138
[TBL] [Abstract][Full Text] [Related]
12. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
Mole AJ; Bell S; Thomson AK; Dissanayake KN; Ribchester RR; Murray LM
J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115
[TBL] [Abstract][Full Text] [Related]
13. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
[TBL] [Abstract][Full Text] [Related]
14. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
[TBL] [Abstract][Full Text] [Related]
15. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
[TBL] [Abstract][Full Text] [Related]
16. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
17. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
Turner BJ; Parkinson NJ; Davies KE; Talbot K
Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
20. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
